Sweeny Nicole, Chief Commercial Officer at KalVista Pharmaceuticals ($KALV), sold shares on the open market four times over the past year for a total of about $158,000. Her most recent sale occurred on February 23, 2026. With no open market purchases, her sales rank 8,890th among 11,678 insiders, far below the average of $8.6 million across about six transactions per insider.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 22, 2026 | KalVista Pharmaceuticals, Inc. | $KALV | Sweeny Nicole | Chief Commercial Officer | M | Restricted Stock Unit | 5000 | $0.00 | 45,000.0000 | 53,883,681 | 10.00% | 0.01% |
| Feb. 21, 2026 | KalVista Pharmaceuticals, Inc. | $KALV | Sweeny Nicole | Chief Commercial Officer | M | Restricted Stock Unit | 6250 | $0.00 | 75,000.0000 | 53,883,681 | 7.69% | 0.01% |
| Feb. 23, 2026 | KalVista Pharmaceuticals, Inc. | $KALV | Sweeny Nicole | Chief Commercial Officer | S | Common Stock | 3975 | $15.57 | 47,003.0000 | 53,883,681 | 7.80% | 0.01% |
| Feb. 22, 2026 | KalVista Pharmaceuticals, Inc. | $KALV | Sweeny Nicole | Chief Commercial Officer | M | Common Stock | 5000 | $0.00 | 50,978.0000 | 53,883,681 | 10.87% | 0.01% |
| Feb. 21, 2026 | KalVista Pharmaceuticals, Inc. | $KALV | Sweeny Nicole | Chief Commercial Officer | M | Common Stock | 6250 | $0.00 | 45,978.0000 | 53,883,681 | 15.73% | 0.01% |
| Jan. 16, 2026 | KalVista Pharmaceuticals, Inc. | $KALV | Sweeny Nicole | Chief Commercial Officer | A | Restricted Stock Unit | 100000 | $0.00 | 100,000.0000 | 53,883,681 | 9999.99% | 0.19% |
| Nov. 21, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Sweeny Nicole | Chief Commercial Officer | M | Common Stock | 6250 | $0.00 | 38,541.0000 | 53,883,681 | 19.36% | 0.01% |
| Nov. 22, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Sweeny Nicole | Chief Commercial Officer | M | Common Stock | 5000 | $0.00 | 43,541.0000 | 53,883,681 | 12.97% | 0.01% |
| Nov. 24, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Sweeny Nicole | Chief Commercial Officer | S | Common Stock | 3813 | $13.45 | 39,728.0000 | 53,883,681 | 8.76% | 0.01% |
| Nov. 21, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Sweeny Nicole | Chief Commercial Officer | M | Restricted Stock Unit | 6250 | $0.00 | 81,250.0000 | 53,883,681 | 7.14% | 0.01% |
| Nov. 22, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Sweeny Nicole | Chief Commercial Officer | M | Restricted Stock Unit | 5000 | $0.00 | 50,000.0000 | 53,883,681 | 9.09% | 0.01% |
| Aug. 25, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Sweeny Nicole | Chief Commercial Officer | S | Common Stock | 1480 | $13.42 | 32,291.0000 | 49,652,878 | 4.38% | 0.00% |
| Aug. 22, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Sweeny Nicole | Chief Commercial Officer | M | Common Stock | 5000 | $0.00 | 33,771.0000 | 49,652,878 | 17.38% | 0.01% |
| Aug. 22, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Sweeny Nicole | Chief Commercial Officer | M | Restricted Stock Unit | 5000 | $0.00 | 55,000.0000 | 49,652,878 | 8.33% | 0.01% |
| Aug. 21, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Sweeny Nicole | Chief Commercial Officer | M | Restricted Stock Unit | 6250 | $0.00 | 87,500.0000 | 49,652,878 | 6.67% | 0.01% |
| Aug. 21, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Sweeny Nicole | Chief Commercial Officer | M | Common Stock | 6250 | $0.00 | 30,635.0000 | 49,652,878 | 25.63% | 0.01% |
| Aug. 22, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Sweeny Nicole | Chief Commercial Officer | S | Common Stock | 1864 | $13.22 | 28,771.0000 | 49,652,878 | 6.08% | 0.00% |
| Feb. 12, 2023 | Praxis Precision Medicines, Inc. | $PRAX | Sweeny Nicole | Chief Commercial Officer | F | Common Stock | 1456 | $3.94 | 38,619.0000 | 0 | 3.63% | 0.00% |
| Jan. 12, 2023 | Praxis Precision Medicines, Inc. | $PRAX | Sweeny Nicole | Chief Commercial Officer | A | Stock Option (Right to Buy) | 120000 | $0.00 | 120,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 12, 2023 | Praxis Precision Medicines, Inc. | $PRAX | Sweeny Nicole | Chief Commercial Officer | A | Stock Option (Right to Buy) | 41085 | $0.00 | 41,085.0000 | 0 | 9999.99% | 0.00% |
| Jan. 7, 2023 | Praxis Precision Medicines, Inc. | $PRAX | Sweeny Nicole | Chief Commercial Officer | F | Common Stock | 2079 | $2.52 | 40,075.0000 | 0 | 4.93% | 0.00% |